mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
2e-11 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
4e-11 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-10 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-08 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
9e-07 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
1e-05 |